Balyasny Asset Management LLC Immunome Inc. Transaction History

Balyasny Asset Management LLC

  • $58 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$11.54 - $22.11 $2.55 Million - $4.88 Million
220,754 Added 142.89%
375,242 $4.54 Million
Q1 2024

May 13, 2024
BUY
$11.01 - $27.34 $1.39 Million - $3.44 Million
125,839 Added 439.24%
154,488 $3.81 Million
Q4 2023

Feb 14, 2024
BUY
$7.3 - $10.73 $209,137 - $307,403
28,649 New
28,649 $306,000

Others Institutions Holding IMNM

# of Institutions
122
Shares Held
47.1M
Call Options Held
322K
Put Options Held
1.91M
View Full List

About Immunome Inc.

IMNM Quotes by TradingView
  • Ticker IMNM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,127,400
  • Market Cap $110M
  • Description
  • Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...
More about IMNM
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email